JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, cilt.17, sa.7, ss.358-362, 2011 (SCI-Expanded)
Background: Effectiveness of anti-tumor necrosis factor (anti-TNF) agents in colchicine-resistant familial Mediterranean fever (FMF) patients has attracted attention in recent years.